Results 1 to 10 of about 132,205 (192)

Inactivated vaccines derived from bovine viral diarrhea virus B3 strain elicit robust and specific humoral and cellular immune responses [PDF]

open access: yesFrontiers in Microbiology
IntroductionBovine viral diarrhea-mucosal disease (BVD-MD) is a significant viral disease in cattle caused by infection with bovine viral diarrhea virus (BVDV). Xinjiang, a major pastoral region in China, is heavily affected by this disease. Owing to the
Ming-Guo Xu   +9 more
doaj   +2 more sources

Leveraging Electron Beam (eBeam) Technology for Advancing the Development of Inactivated Vaccines [PDF]

open access: yesVaccines
This review provides an overview of electron beam (eBeam) technology and its applications across a wide variety of disciplines. More importantly, it discusses this technology’s advantages and its benefits in developing inactivated vaccines.
Ruvindu Perera   +3 more
doaj   +2 more sources

Quality control procedure for Coccidial vaccines versus different routes of immunization [PDF]

open access: yesVeterinary World, 2022
Background and Aim: Coccidiosis is an enteric infection caused by a protozoon (Eimeria tenella). Coccidiosis is known to have a negative impact on the economy. Coccidiosis is controlled using anticoccidial drugs, antibiotics, and vaccines.
Arwa Elnaggar, Hala Mahmoud, Sahar Saber
doaj   +1 more source

30-Year Development of Inactivated Virus Vaccine in China

open access: yesPharmaceutics, 2023
Inactivated vaccines are vaccines made from inactivated pathogens, typically achieved by using chemical or physical methods to destroy the virus’s ability to replicate.
Jinrong Shi   +4 more
doaj   +1 more source

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations

open access: yesVaccines, 2023
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and vaccination is critical for preventing further spread or resurgence of the outbreak ...
Lidan Hu   +8 more
doaj   +1 more source

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

open access: yesEmerging Microbes and Infections, 2021
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries.
Jialu Zhang   +18 more
doaj   +1 more source

Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines [PDF]

open access: yesPeerJ, 2023
Inactivated vaccines are one of the most effective strategies for controlling the coronavirus disease 2019 (COVID-19) pandemic. However, the response genes for the protective effect of inactivated vaccines are still unclear.
Hongquan Chen   +5 more
doaj   +2 more sources

Inactivated vaccine against Aujeszky's disease

open access: yesVeterinary World, 2021
Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on "Kordai" virus strain.
Zhanat B. Kondibaeva   +9 more
openaire   +4 more sources

EVALUATION OF RECOMBINANT AVIAN INFLUENZA COMPARED TO INACTIVATED VACCINES TO INDUCE IMMUNE RESPONSE IN CHICKEN [PDF]

open access: yesArab Universities Journal of Agricultural Sciences, 2018
The present Avian Influenza epidemic in Egypt is consider one of the major problems facing the poultry field and caused by circulation of genetically and antigenetically diverse influenza H5N1 viruses.
Dalia Omar, K. El-Dougdoug, B. Othman
doaj   +1 more source

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

open access: yesExpert Review of Vaccines, 2023
Introduction Approximately half of the 13.4 billion COVID-19 vaccine doses administered globally were inactivated or viral vector platforms. The harmonization and optimization of vaccine regimens has become a key focus of policymakers and health-care ...
Anthony M. Marchese   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy